title: Re: Crawford et al.: long-term tolerability and efficacy of degarelix: 5-year results from a phase III extension trial with a 1-arm crossover from leuprolide to degarelix (Urology 2014;83:1122-1128).
authors.affiliation: Department of Urology, Acıbadem University School of Medicine, İstanbul, Turkey.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Sofikerim
mesh_terms: D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D008297:Male; D009842:Oligopeptides / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D009842:Oligopeptides; D016729:Leuprolide